NewsRoom Articles - Page 217 of 609

ThursdayJan 20, 2022 1:04 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks Great Start to its 2022 R&D Programs Following Independent Review Board Approval

Lexaria received independent review board approval for its HYPER-H21-4 human clinical study for hypertension treatment The stage is also set for other R&D programs for the 2022 calendar year, including HOR-A22-1, DEM-A22-1, RHEUM-A22-1 and DIAB-A22-1 All of these 2022 R&D programs are fully funded, with Lexaria having raised approximately $15 million over the 2021 calendar year Lexaria believes that these programs will build significant value for its stakeholders and pursue policies for substantial improvements to human health In late 2021, Lexaria Bioscience (NASDAQ: LEXX) announced several new and ongoing R&D programs for its patented DehydraTECH(TM) technology. While making the announcement,…

ThursdayJan 20, 2022 4:20 am

420 with CNW — Study Finds That Hemp Compounds Could Block Coronavirus Infection

New research carried out by researchers at the Oregon State University and the Oregon Health and Science University has discovered that some hemp compounds may be able to prevent SARS-CoV-2 from entering cells in the human body. SARS-CoV-2 is the virus that causes the coronavirus infection. The study’s findings were reported in the “Journal of Natural Products.” Hemp is a strain of the marijuana plant that has been grown for use in various commercial applications. The plant has very small amounts of THC (tetrahydrocannabinol), which is one of the two primary compounds found in cannabis, the other being CBD. Unlike…

WednesdayJan 19, 2022 4:20 pm

420 with CNW — Future Cannabis Impairment Testing May Rely on Brain Scans

Legalizing cannabis has brought forth a ton of benefits: the state-legal industry has created hundreds of thousands of new jobs, generated billions of dollars in revenue and filled state coffers with billions of cannabis tax dollars. This money has been used to fund plenty of social-equity programs designed to help the underprivileged as well as communities that were disproportionately affected by the war on drugs. However, making recreational cannabis legal has made traffic policing much more difficult. While we have a relatively accurate way of testing how drunk an individual is, no such test exists for cannabis. At best, current…

WednesdayJan 19, 2022 4:20 am

420 with CNW — Mississippi Mom Believes Legalizing Medical Cannabis Would Transform Epileptic Daughter’s Health

We don’t know a lot about how cannabis affects the body, although anecdotal accounts and preliminary research shows that cannabis has some therapeutic ability. However, the consensus among most experts is that we need more research on cannabis. In the meantime, what we do know about the controversial plant is significant enough. Studies have found that cannabis can reduce seizures suffered by children with intractable epilepsy. Furthermore, the FDA has approved a CBD-based drug called Epidiolex to treat two rare and severe forms of pediatric epilepsy: Dravet Syndrome and Lennox Gastaut Syndrome. Gaining access to such cannabis-based epilepsy drugs is…

TuesdayJan 18, 2022 4:20 pm

420 with CNW — Top National Intelligence Official Eases Cannabis Restrictions on Federal Employees

In a new memo, Avril Haines, director of National Intelligence, stated that federal employers should be discrete when it comes to individuals with marijuana investments in their stock portfolios and shouldn’t flatly reject security clearance applicants over past use of marijuana. Haines stated that even with more states legalizing cannabis across the country, its use by individuals in positions that required national security clearance remained an area of concern, noting that the herb’s use should be considered in the application process. She explained that the illegal use of the controlled substance could raise security concerns about a person’s trustworthiness and…

TuesdayJan 18, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) in 2021, Year in Review

RWB marked 2021 with strategic acquisitions, with the most notable of them being Acreage Holdings Inc. and a 45,000 square foot greenhouse in Apopka, Florida These strategic investments would see the company steadily grow its revenue, marking a 93% year-over-year growth by Q3 The year also marked notable appointments, including Ryan Costello and Colby De Zen, both into the company’s Board of Directors RWB is confident that the foundations laid down in 2021 will play a vital role in the company’s growth in 2022, as well as creating shareholder value Since its inception, Red White & Bloom Brands (CSE: RWB)…

TuesdayJan 18, 2022 4:20 am

420 with CNW — California Disburses $100M in Support of Cannabis Business Development

Last week, officials in California announced that the state had allocated $100 million in funding for the development of local cannabis markets, which would initially be used to help marijuana businesses become fully licensed. The California Department of Cannabis Control distributed the funds to 17 counties and cities where there are unequal numbers of provisional cannabis licenses. Some funding was also directed to areas with established social equity programs. This comes months after the department’s announcement that it was accepting applications for the local jurisdiction assistance grant program. The temporary licensing category was scheduled to expire on Jan. 1, 2022,…

FridayJan 14, 2022 4:20 pm

420 with CNW — CPG Trends That Marijuana Businesses Should Consider Implementing

Since the pandemic begun, there have been shifts in consumer purchasing habits with emerging technologies and packaging innovations such as digitization, remote analytics and AI leading to the development of a new level of company efficiencies. While not every packaging innovation can be applied to marijuana firms, some trends transforming the consumer packaged goods sector should be considered, including the following: AI and Digitization Digitization is helping improve product traceability and develop packaging automation efficiencies in the consumer packaged goods sector. The marijuana sector doesn’t have industry software solutions that allow them to collect, organize and analyze their packaging and…

FridayJan 14, 2022 9:00 am

After a Successful 2021, Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks Off 2022 With New Media Strategy, Plans for Clinical Study Advancements

Lexaria has multiple studies planned that will commence early in 2022 DehydraTECH increases Lexaria’s ability to leverage multiple markets, including the growing CBD sector, which is expected to meet and exceed $108 billion in revenue by 2027 DehydraTECH can increase the efficacy of the drugs being administered, offering faster absorption and lowering the delivery time In a strategic move to start off 2022, Lexaria Bioscience (NASDAQ: LEXX), a global innovator of drug delivery platforms, has announced that it has signed an advertising and media contract with financial technology company SRAX (NASDAQ: SRAX). The contract will facilitate media buys and digital…

FridayJan 14, 2022 4:20 am

420 with CNW — New Study Finds Cannabis Breathalyzers Provide Inaccurate Results

New research has found that cannabis breathalyzers are inconsistent in measuring THC impairment. THC (tetrahydrocannabinol) is the primary psychoactive compound in marijuana that induces a high. This compound usually binds with receptors in the brain that control mood and pain, among other feelings. The study was carried out in Australia by University of Sydney researchers. For their research, the investigators conducted an analysis of 28 studies on the concentration of THC in saliva and blood and driving performance. The studies included in the analysis focused on how THC divided attention and impacted an individual’s reaction time. These two skills are…

News and publishing service for cannabis related companies

Contact us: 512.354.7000